Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 6.18B |
| Enterprise Value | 5.91B |
| P/E Ratio | 60.11 |
| PEG Ratio | 2.7 |
| Price/Sales Ratio | 6.68 |
| Price/Book Ratio | 3.2 |
| Enterprise/Revenue | 6.28 |
| Enterprise/EBITDA | 44.75 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.11 |
| Operating Margin | 0.1 |
| Return On Assets | 0.05 |
| Return On Equity | 0.05 |
| Revenue | 827.14M |
| Revenue/Share | 2.02 |
| Gross Profit | 474.67M |
| EBITDA | 165.69M |
| Net Income | 65.09M |
| Diluted EPS | 0.16 |
| Total Cash | 584.31M |
| Total Cash/Share | 1.4 |
| Total Debt | 2.16M |
| Total Debt/Equity | 0 |
| Current Ratio | 5.38 |
| Book Value Per Share | 4.23 |
| 52-Week Change | -18.72 |
| 52-Week High | 18.47 |
| 52-Week Low | 11.42 |
| Moving Average 50 Days | 14.15 |
| Moving Average 200 Days | 13.89 |
| Average Volume | 14.75M |
| Shares Outstanding | 417.6M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.08 |
| Trailing Annual Dividend Yield | 0.56 |
| Payout Ratio | 0.16 |
| Last Split Factor | N/A |
| Last Split Date | N/A |